Skip to main content
VCbacked
Log inGet Started

Cedilla Therapeutics

Cambridge, United States

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

$25.0M raised
Oct 2021
Series B
BiotechnologyHealth CareTherapeutics

Top Investors

RA Capital ManagementEli LillyJanus Henderson InvestorsThird Rock VenturesCasdin Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cedilla Therapeutics

How much funding has Cedilla Therapeutics raised?
Cedilla Therapeutics has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in October 2021.
Who are Cedilla Therapeutics's investors?
Cedilla Therapeutics's investors include RA Capital Management, Eli Lilly, Janus Henderson Investors, Third Rock Ventures, Casdin Capital.
Where is Cedilla Therapeutics headquartered?
Cedilla Therapeutics is headquartered in Cambridge, United States.
What does Cedilla Therapeutics do?
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
What stage is Cedilla Therapeutics at?
Cedilla Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cedilla Therapeutics — Funding & Investors." VCBacked, October 25, 2021, https://www.vcbacked.co/company/cedilla-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2021). Cedilla Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cedilla-therapeutics
Wikipedia (cite web)
{{cite web |title=Cedilla Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cedilla-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K